Cargando…
LINC-DUBR Suppresses Malignant Progression of Ovarian Cancer by Downregulating miR-107 to Induce SMAC Expression
BACKGROUND: LINC-DUBR may be a potential therapeutic target in ovarian cancer (OC). The purpose of this research was to explore the impact of miR-107 on the tumorigenicity of OC and its underlying molecular mechanisms. METHODS: RT-qPCR was adopted to measure the expression of LINC-DUBR and miR-107 i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913066/ https://www.ncbi.nlm.nih.gov/pubmed/35281523 http://dx.doi.org/10.1155/2022/4535655 |